Insider · CIK 0001770650
Heather Raines
Files at PVCT (PROVECTUS BIOPHARMACEUTICALS, INC.). First filing -, latest -.
Heather Raines files SEC Form 4 as CFO at PVCT (PROVECTUS BIOPHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Heather Raines has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | PVCT PROVECTUS BIOPHARMACEUTICALS, INC. | AGrant or award Stock Options (Right to Buy)derivative | +4,197,890 | $0.00 | $0 | 4,197,890 | Dec 4, 2024 |
Questions about Heather Raines
Answered from the filings on this page, as of the latest one.
Is Heather Raines buying or selling?
Heather Raines has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Heather Raines's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Heather Raines has 0.
Where does Heather Raines file Form 4?
Heather Raines has filed Form 4 at PVCT (PROVECTUS BIOPHARMACEUTICALS, INC.) as CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.